Pure Global
NCT06259448

Feasibility of Optimizing Organized Cervical Cancer Screening by Urine Self-sampling

University Hospital, Bordeaux·ClinicalTrials.gov·otherRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Cervical Cancer
Drug/Device/Intervention
urine self-sampling
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
University Hospital, Bordeaux
Location
Bordeaux, France
Timeline & enrollment
Phase
N/A
Start date
Nov 13, 2023
End date
Nov 01, 2024
Enrollment
170 participants
Primary outcome

Urine self-sampling acceptability

Summary

This project addresses the issue of promoting organized cervical cancer screening (CCS) from
 the perspective of the use of urine self-sampling (USS). Via a prospective and monocentric
 study, the present study aims to evaluate the acceptability of women to collect a urine
 self-sample and to respond to a questionnaire on their feelings about this screening method.

ICD-10 classifications
Severe cervical dysplasia, not elsewhere classifiedMild cervical dysplasiaModerate cervical dysplasiaCarcinoma in situ: Cervix, unspecifiedCervical root disorders, not elsewhere classified
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06259448
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06259448 through Pure Global AI's free database. This phase not specified trial is sponsored by University Hospital, Bordeaux and is currently Recruiting. The study focuses on Cervical Cancer. Target enrollment is 170 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.